26-A-19022-ACC Sodium-glucose cotransporter-2 inhibitors and clinical outcomes in cardiac sarcoidosis: Evidence from a real-world multicenter cohort
Recommended Citation
Olumuyide EO, Milhem F, Hattab M, Munshi H, Hu J-R. 26-A-19022-ACC Sodium-Glucose Cotransporter-2 Inhibitors and Clinical Outcomes in Cardiac Sarcoidosis: Evidence from a Real-World Multicenter Cohort. Journal of the American College of Cardiology (JACC). 2026;87(13):A744. doi:10.1016/j.jacc.2026.02.1928
Type
Abstract
Affiliations
Advocate Illinos Masonic Medical Center